Vanda Pharmaceuticals (VNDA) Earnings Date, Estimates & Call Transcripts → Get out of dollars—get into America’s new money instead (From Stansberry Research) (Ad) Free VNDA Stock Alerts $5.01 +0.09 (+1.83%) (As of 05/30/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateJul. 25EstimatedActual EPS (May. 8) -$0.07 Missed By -$0.12 Consensus EPS (May. 8) $0.05 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVNDA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VNDA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad American AlternativeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW Vanda Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.06) EPSNext Year EPS Consensus Estimate: ($0.33) EPSVNDA Earnings Date and InformationVanda Pharmaceuticals last posted its quarterly earnings data on May 8th, 2024. The biopharmaceutical company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by $0.12. The business earned $47.46 million during the quarter, compared to analysts' expectations of $48.50 million. Vanda Pharmaceuticals has generated ($0.08) earnings per share over the last year (($0.08) diluted earnings per share). Earnings for Vanda Pharmaceuticals are expected to decrease in the coming year, from ($0.06) to ($0.33) per share. Vanda Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off prior year's report dates.Read More Vanda Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/25/2024(Estimated)------- 5/8/2024Q1 2024$0.05($0.07)($0.12)($0.07)$48.50 million$47.46 million2/7/2024Q4 2023($0.09)($0.04)+$0.05($0.04)$37.00 million$45.27 million7/27/2023Q2 2023($0.13)$0.03+$0.16$0.03$49.00 million$46.06 million5/3/2023Q1 2023-$0.06+$0.06$0.06-$62.50 million2/8/2023Q4 2022$0.08$0.12+$0.04$0.12$67.60 million$64.48 million11/2/2022Q3 2022$0.10$0.06($0.04)$0.06$71.00 million$65.32 millionUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW8/3/2022Q2 2022$0.11$0.05($0.06)$0.05$67.00 million$64.39 million5/5/2022Q1 2022($0.01)($0.11)($0.10)($0.11)$58.00 million$60.19 million 2/23/2022Q4 2021$0.09$0.12+$0.03$0.12$65.90 million$68.02 million 11/3/2021Q3 2021$0.20$0.14($0.06)$0.14$73.50 million$70.10 million 7/28/2021Q2 2021$0.17$0.17-$0.17$71.00 million$67.90 million 5/5/2021Q1 2021$0.14$0.15+$0.01$0.15$23.50 million$62.67 million 2/10/2021Q4 2020$0.10$0.15+$0.05$0.15$64.00 million$67.65 million 10/28/2020Q3 2020$0.08$0.11+$0.03$0.11$64.00 million$60.31 million 8/5/2020Q2 2020$0.08$0.16+$0.08$0.16$63.00 million$62.21 million 5/6/2020Q1 2020$0.01$0.01-$0.01$57.53 million$58.00 million 2/25/2020Q4 2019$0.12$0.08($0.04)$0.08$59.77 million$60.93 million 11/6/2019Q3$0.07$1.84+$1.77$1.84$58.33 million$59.49 million 7/31/2019Q2($0.03)$0.21+$0.24$0.21$54.19 million$59.06 million Vanda Pharmaceuticals Earnings - Frequently Asked Questions When is Vanda Pharmaceuticals's earnings date? Vanda Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 25th, 2024 based off last year's report dates. Learn more on VNDA's earnings history. Did Vanda Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Vanda Pharmaceuticals (NASDAQ:VNDA) missed the analysts' consensus estimate of $0.05 by $0.12 with a reported earnings per share (EPS) of ($0.07). Learn more on analysts' earnings estimate vs. VNDA's actual earnings. How much revenue does Vanda Pharmaceuticals generate each year? Vanda Pharmaceuticals (NASDAQ:VNDA) has a recorded annual revenue of $192.64 million. How much profit does Vanda Pharmaceuticals generate each year? Vanda Pharmaceuticals (NASDAQ:VNDA) has a recorded net income of $2.51 million. VNDA has generated -$0.08 earnings per share over the last four quarters. What is Vanda Pharmaceuticals's EPS forecast for next year? Vanda Pharmaceuticals's earnings are expected to decrease from ($0.06) per share to ($0.33) per share in the next year. More Earnings Resources from MarketBeat Related Companies: XOMA Earnings Verastem Earnings Emergent BioSolutions Earnings Lexicon Pharmaceuticals Earnings Rigel Pharmaceuticals Earnings Gossamer Bio Earnings Regulus Therapeutics Earnings VBI Vaccines Earnings AnaptysBio Earnings OPKO Health Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Abercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the Dip This page (NASDAQ:VNDA) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiden Nomination CANCELED?The Freeport SocietyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeGet out of dollars—get into America’s new money insteadStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
